申联生物：与中国农业科学院兰州兽医研究所签订疫苗项目合作开发合同

Core Viewpoint - The company has signed cooperative contracts with the Lanzhou Veterinary Research Institute of the Chinese Academy of Agricultural Sciences and other entities to develop multi-valent vaccines for swine and cattle diseases, indicating a strategic move to enhance its vaccine portfolio and collaborative research efforts [1] Group 1 - The company is collaborating on the development of a tri-valent vaccine for swine diseases including Foot-and-Mouth Disease (FMD) type O/A, Classical Swine Fever (CSF), and Pseudorabies [1] - The company is also involved in the development of a tri-valent vaccine for cattle diseases including FMD type O/A, Viral Diarrhea/Mucosal Disease, and Infectious Bovine Rhinotracheitis [1] - The collaboration entails shared responsibilities and costs among the parties involved, with the resulting technological achievements and intellectual property being jointly owned by the company and the Lanzhou Veterinary Research Institute [1]